Want create site? With Free visual composer you can do it easy.

NRNP 6665 Special Considerations Related to Prescribing for Children and Adolescents

NRNP 6665 Special Considerations Related to Prescribing for Children and Adolescents

 

There is probably no greater responsibility that the psychiatric-mental health nurse practitioner assumes than the responsibility of prescribing medications. While patients can be harmed by psychotherapy, the level and intensity of the harm generally does not approach the same level of harm that can occur from improper prescribing. PMHNPs must understand their responsibility, both at the state and federal levels, when it comes to prescribing medications.

This week, you will explore the particular clinical considerations associated with prescribing for children and adolescents.

Learning Objectives

NRNP 6665 Special Considerations Related to Prescribing for Children and Adolescents

 

Students will:

  • Recommend psychopharmacological interventions for children and adolescents
  • Recommend nonpharmacological interventions for children and adolescents in mental health settings
  • Analyze clinical decision making related to treatment of children and adolescents in mental health settings
  • Evaluate mastery of nurse practitioner knowledge in preparation for the nurse practitioner national certification examination
  • NRNP 6665 Special Considerations Related to Prescribing for Children and Adolescents
  • Create a study plan for the nurse practitioner national certification examination

Learning Resources

Required Readings (click to expand/reduce)

Click here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: NRNP 6665 Special Considerations Related to Prescribing for Children and Adolescents

 

Hilt, R. J., & Nussbaum, A. M. (2016). DSM-5 pocket guide for child and adolescent mental health. American Psychiatric Association Publishing.

 

Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., & Taylor, E. A. (2015). Rutter’s child and adolescent psychiatry (6th ed.). Wiley Blackwell.

  • Chapter 43, “Pharmacological, Medically-Led and Related Treatments”

Walden University. (n.d.). Developing SMART goals. https://academicguides.waldenu.edu/ld.php?content_id=51901492

 

 

Zakhari, R. (2020). The psychiatric-mental health nurse practitioner certification review manual. Springer.

  • Chapter 5, “Psychopharmacology”

Required Media (click to expand/reduce)

 

CriticalThinkRx. (2019, June 9). Module 5: Specific drug classes: Focus on adverse effects [Video]. YouTube. https://youtu.be/Gbq6RnOsGKQ

CriticalThinkRx. (2019, June 9). Module 2: Use of psychotropics with youth_prevalence and concerns [Video]. YouTube. https://youtu.be/NRef-g4Ding

Photo Credit: [BrianAJackson]/[iStock / Getty Images Plus]/Getty Images
In Week 3, you will review psychopharmacological treatments for mental health disorders, focusing specifically on prescribing for children and adolescents. You will also use your pretest results from this week to create a study plan for the PMHNP certification exam.
Next Week

To go to the next week:
Week 3

Click here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: NRNP 6665 Special Considerations Related to Prescribing for Children and Adolescents

Did you find apk for android? You can find new Free Android Games and apps.